Skip to content

Dismantling Exposure, Relaxation, and Rescripting Therapy

Exposure, Relaxation, Rescripting Therapy (ERRT) Dismantling

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02236377
Acronym
ERRT
Enrollment
50
Registered
2014-09-10
Start date
2014-08-31
Completion date
2025-08-31
Last updated
2024-07-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frequent Trauma-related Nightmares

Keywords

ERRT, Nightmares, Sleep, Trauma, PTSD

Brief summary

The purpose of this case series dismantling study is to extend previous findings regarding the efficacy of a brief treatment for chronic post-trauma nightmares by examining the dose effect and mechanism of change. Exposure, relaxation, and rescripting therapy (ERRT) is a promising psychological intervention developed to target trauma-related nightmares and sleep disturbances. ERRT has exhibited strong support in reducing the frequency and intensity of nightmares, as well as improving overall sleep quality in both civilian and veteran samples. In addition, significant decreases in PTSD and depression symptoms have been reported following treatment (Davis et al., 2011; Davis & Wright, 2007; Long et al., 2011; Swanson, Favorite, Horin, & Arnedt, 2009). ERRT is currently an evidence-level B suggested treatment (Cranston, Davis, Rhudy, & Favorite, 2011). Despite this evidence, the mechanism of change for ERRT remains unclear. We propose to conduct a set of case series in order to examine the possible mechanisms: psycho-education, dose response for exposure, and no exposure components of the treatment. Each part of the treatment is theorized to contribute to the improved treatment outcome and it is hypothesized that participants will benefit no matter what group they are in. All participants will receive 5 to 6 treatment sessions, conducted once per week for about 90 minutes, of a modified version of ERRT.

Interventions

Brief cognitive behavioral treatment targeting trauma-related nightmares and sleep problems

Sponsors

University of Tulsa
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older at the time of the intake, * experienced a traumatic event, as defined by the Diagnostic and Statistical Manual (DSM-5), * have approximately one nightmare each week for the past month * be able to read and speak English.

Exclusion criteria

* age of 17 or younger * acute or apparent psychosis * unmedicated bipolar disorder * intellectual disability * active suicidality, * recent parasuicidal behaviors * untreated substance use disorder in past 6 months

Design outcomes

Primary

MeasureTime frameDescription
Nightmare Frequency Past Weekup to 6 months followupThis fill-in-the-blank variable assesses the number of nights the individual experienced nightmares in the past week (range = 0 - 7 nights). Higher values indicate more nights with nightmares (worse outcome).

Countries

United States

Contacts

Primary ContactJoanne L Davis, PhD
joanne-davis@utulsa.edu9186312875
Backup ContactLucia D Villarreal, MS
LDV0460@utulsa.edu9186313976

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026